9F1 — Diagonal Bio AB Balance Sheet
0.000.00%
Last trade - 00:00- €4.14m
- €3.88m
- SEK0.02m
Annual balance sheet for Diagonal Bio AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | — | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 3.67 | 20.8 | 13.6 | 2.97 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.295 | 0.466 | 0.68 | 0.523 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Current Assets | 4 | 21.4 | 14.5 | 4.73 |
| Net Property, Plant And Equipment | — | — | — | 0.021 |
| Net Intangible Assets | ||||
| Total Assets | 9.97 | 36 | 34 | 28.5 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 1.08 | 2.14 | 2.78 | 7.26 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 1.08 | 2.14 | 2.78 | 7.26 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 8.89 | 33.9 | 31.3 | 21.2 |
| Total Liabilities & Shareholders' Equity | 9.97 | 36 | 34 | 28.5 |
| Total Common Shares Outstanding |